MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0000306
Vannsh Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹50.34 Cr
▲ 13% YoY
Net profit · FY 2024
₹56.55 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹6.21 Cr
EBITDA margin 12.3%
Authorised capital
₹22.5 Cr
Registered with MCA
Paid-up capital
₹21.43 Cr
Issued & subscribed
Open charges
₹54.78 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
64
Provident fund records
About Vannsh Life Sciences Private Limited
Data last updated:
Vannsh Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 16 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2014PTC094869. Its GSTIN is 36AAECV8445R1ZE (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹22.5 Cr and a paid-up capital of ₹21.43 Cr. It is led by directors including Venkateswarreddy Sandadi and Bidyut Roy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No. 8 – 2 – 293/82/B/55/A Gamut Di Lusso Apt # 2B Road No.12 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2024, the company reported a revenue of ₹50.34 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹56.55 Lakh (net margin 1.1%) and EBITDA of ₹6.21 Cr (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 137% over five years.
The company has about 64 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vannsh Life Sciences. As per MCA filings, the company has open charges of ₹54.78 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹15.72 Cr; the latest was in March 2023. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is K. A. Malle Pharmaceuticals Limited with revenue of ₹51.47 Cr.
Vannsh Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0000306). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vannshlifesciences.com.
Company details
CIN U24100TG2014PTC094869
Registration Number 094869
Incorporation Date 16 July 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0000306
Recognitions & Rankings of Vannsh Life Sciences
Contact details
Vannsh Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is vannshlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No. 8 – 2 – 293/82/B/55/A Gamut Di Lusso Apt # 2B Road No.12 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, API Manufacturers
To see the full contact details of Vannsh Life Sciences Private Limited, buy the company report.
Comprehensive company report
Vannsh Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vannsh Life Sciences operates one associated brand: Vannsh Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in developing and manufacturing pharmaceutical APIs and intermediates for global markets. | vannshlifesciences.com |
Business activity
The main business activity of Vannsh Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vannsh Life Sciences Private Limited, buy the company report.
Financials of Vannsh Life Sciences Private Limited
FY 2024 filings availableVannsh Life Sciences Private Limited reported revenue of ₹50.34 Cr (up 13% YoY) for FY 2024.
Revenue · FY 2024
₹50.34 Cr ▲ 13%
Net profit · FY 2024
₹56.55 Lakh margin 1.1%
EBITDA · FY 2024
₹6.21 Cr margin 12.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 44%
5 years · compounded
▲ 137%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 205%
5 years · compounded
▲ 280%
Revenue has grown at a compounded annual rate (CAGR) of 137% over five years, including 13% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vannsh Life Sciences Private Limited, buy the company report.
Board of directors of Vannsh Life Sciences Private Limited
Vannsh Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkateswarreddy Sandadi | Director | 16 Jul 2014 | 12 Years 3 Months | Current |
| Bidyut Roy Also directs: Arbrown India Trading Private Limited | Director | 01 Jul 2023 | 3 Years 4 Months | Current |
| Sridevi Sandadi | Director | 16 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Vannsh Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ranq Remedies Private Limited | ₹51.43 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Kreative Organics Private Limited | ₹50.74 Cr (FY 2023) | 6.0% | Hyderabad, Telangana, India | |||
| Vannsh Life Sciences Private Limitedthis company | ₹50.34 Cr (FY 2024) | ₹56.55 Lakh | 1.1% | 13.0% | 64 | Hyderabad, Telangana, India |
| Ultratech India Limited | ₹50.24 Cr (FY 2025) | 84.0% | Navi Mumbai, Maharashtra, India | |||
| GGC Chemicals & Pharmaceuticals Private Limited | ₹50.18 Cr (FY 2025) | 202.0% | Savli, Gujarat, India | |||
| Aparna Organics Limited | ₹50.16 Cr (FY 2023) | -57.0% | Hyderabad, Telangana, India | |||
| Atlas Life Sciences (India) Private Limited | ₹49.58 Cr (FY 2025) | 1010.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Vannsh Life Sciences Private Limited, buy the company report.
Auditor
Vannsh Life Sciences Private Limited is audited by LEELA SUNDARAM & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LEELA SUNDARAM & CO | FY 2023 | 010309S |
Shareholding
The shareholding of Vannsh Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vannsh Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹54.78 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2024 | 101034268 | Hdfc Bank Limited | ₹36.74 Lakh | Open | |
| 29 Dec 2022 | 100675184 | Axis Bank Limited | ₹21.82 Cr | Open | |
| 27 Feb 2017 | 100093761 | Canara Bank | ₹32.59 Cr | Open |
To see the full charge records of Vannsh Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Vannsh Life Sciences Private Limited has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹15.72 Cr; the latest was in March 2023.
Total deals
5
Rights issues
2
Secondary share transfers
2
Funding round
1
Disclosed funding
₹15.72 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Funding round | ₹15.72 Cr | Investors: AR Brown Co Limited |
| Apr 2022 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
| Mar 2020 | Rights issue | ₹3 Cr | Investors: 2 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2018 | Rights issue | ₹5.01 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vannsh Life Sciences Private Limited has 2 court cases on record: 1 filed by Vannsh Life Sciences, 1 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Civil suit | Filed against the company by Forel Labs Pvt Ltd | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh and 1 other | Disposed |
To see the full case history of Vannsh Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vannsh Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vannsh Life Sciences Private Limited has a workforce of 64 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
64
Active EPFO establishments
1
Employee growth
6.67%
GST
Vannsh Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECV8445R1ZE | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vannsh Life Sciences Private Limited, buy the company report.
Recent activity
Vannsh Life Sciences Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Bidyut Roy ceased to be Additional Director on 29 Sep 2023.
Charges
A charge with Axis Bank Limited of Rs. 21.82 Cr registered on 29 Dec 2022 with Charge ID 100675184 was modified on 30 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.37 Cr with Charge ID 101034268 was registered on 04 Dec 2024.
AGM
Vannsh Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Canara Bank of Rs. 32.59 Cr registered on 27 Feb 2017 with Charge ID 100093761 was modified on 14 Jun 2024.
Filing
Vannsh Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Bidyut Roy ceased to be Additional Director.
Appointed
Bidyut Roy was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 21.82 Cr with Charge ID 100675184 was registered on 29 Dec 2022.
Charges
A charge with Canara Bank amounted to Rs. 32.59 Cr with Charge ID 100093761 was registered on 27 Feb 2017.
Ceased
Suresh Pathak ceased to be Additional Director.
Ceased
Venkata Ravindra Koganti ceased to be Director.
Appointed
Sridevi Sandadi was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Vannsh Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 16 July 2014 (12+ years old) and is registered under CIN U24100TG2014PTC094869.
Vannsh Life Sciences has 3 current directors:
- Venkateswarreddy Sandadi - Director
- Bidyut Roy - Director
- Sridevi Sandadi - Director
The latest financial statements of Vannsh Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Vannsh Life Sciences is 36AAECV8445R1ZE, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vannsh Life Sciences is U24100TG2014PTC094869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vannsh Life Sciences has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Vannsh Life Sciences was incorporated on 16 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vannsh Life Sciences has 5 deals on record (2 rights issues, 2 secondary share transfers, 1 funding round), with disclosed funding of ₹15.72 Cr; the latest was in March 2023.
The peers of Vannsh Life Sciences by revenue are K. A. Malle Pharmaceuticals Limited, Ranq Remedies Private Limited, Kreative Organics Private Limited, Ultratech India Limited, GGC Chemicals & Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bidyut Roy ceased to be Additional Director on 29 Sep 2023. Bidyut Roy was appointed as Director on 01 Jul 2023. Suresh Pathak ceased to be Additional Director on 11 Aug 2015. Vannsh Life Sciences has 6 board changes on record in total.
Yes, Vannsh Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0000306).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages